Fluorescence image-guided surgery: A perspective on contrast agent development

Connor W. Barth, Summer L. Gibbs

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Scopus citations

Abstract

In the past several decades, a number of novel fluorescence image-guided surgery (FGS) contrast agents have been under development, with many in clinical translation and undergoing clinical trials. In this review, we have identified and summarized the contrast agents currently undergoing clinical translation. In total, 39 novel FGS contrast agents are being studied in 85 clinical trials. Four FGS contrast agents are currently being studied in phase III clinical trials and are poised to reach FDA approval within the next two to three years. Among all novel FGS contrast agents, a wide variety of probe types, targeting mechanisms, and fluorescence properties exists. Clinically available FGS imaging systems have been developed for FDA approved FGS contrast agents, and thus further clinical development is required to yield FGS imaging systems tuned for the variety of contrast agents in the clinical pipeline. Additionally, study of current FGS contrast agents for additional disease types and development of anatomy specific contrast agents is required to provide surgeons FGS tools for all surgical specialties and aßociated comorbidities. The work reviewed here represents a significant effort from many groups and further development of this promising technology will have an enormous impact on surgical outcomes acroß all specialties.

Original languageEnglish (US)
Title of host publicationMolecular-Guided Surgery
Subtitle of host publicationMolecules, Devices, and Applications VI
EditorsSylvain Gioux, Summer L. Gibbs, Brian W. Pogue
PublisherSPIE
ISBN (Electronic)9781510632073
DOIs
StatePublished - Jan 1 2020
EventMolecular-Guided Surgery: Molecules, Devices, and Applications VI 2020 - San Francisco, United States
Duration: Feb 1 2020Feb 2 2020

Publication series

NameProgress in Biomedical Optics and Imaging - Proceedings of SPIE
Volume11222
ISSN (Print)1605-7422

Conference

ConferenceMolecular-Guided Surgery: Molecules, Devices, and Applications VI 2020
CountryUnited States
CitySan Francisco
Period2/1/202/2/20

Keywords

  • Clinical development
  • Clinical trial
  • Contrast agent
  • Fluorescence
  • Fluorescence imaging system
  • Image-guided surgery
  • Near-infrared fluorescence

ASJC Scopus subject areas

  • Electronic, Optical and Magnetic Materials
  • Biomaterials
  • Atomic and Molecular Physics, and Optics
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Fluorescence image-guided surgery: A perspective on contrast agent development'. Together they form a unique fingerprint.

  • Cite this

    Barth, C. W., & Gibbs, S. L. (2020). Fluorescence image-guided surgery: A perspective on contrast agent development. In S. Gioux, S. L. Gibbs, & B. W. Pogue (Eds.), Molecular-Guided Surgery: Molecules, Devices, and Applications VI [112220J] (Progress in Biomedical Optics and Imaging - Proceedings of SPIE; Vol. 11222). SPIE. https://doi.org/10.1117/12.2545292